Philips Trilogy Evo Ventilator Recall Issued Over Air, Dust Contamination Risks
This is the latest in a string of Philips CPAP and ventilators recalls over the last several years, with most involving toxic sound abatement foam.
This is the latest in a string of Philips CPAP and ventilators recalls over the last several years, with most involving toxic sound abatement foam.
Recalled Dräger ventilators contain PE-PUR sound insulation foam that could release toxic gases, causing similar problems linked to a massive Philips CPAP recall issued more than two years ago.
An air flow sensor in the recalled Philips Trilogy Evo, Garbin Evo, and Aeris EVO ventilators may not detect the build-up of debris in the devices, which could lead to low blood oxygen, serious injuries and death.
At least four injuries and one death have been linked to the recalled Ballard Access infant ventilator systems.
Supposedly repaired Trilogy and Garbin Plus Ventilators may experience silicone foam adhesive failure, which could lead to airpaths being blocked, putting ventilator patients at risk.
The FDA warns some reworked Trilogy 100 and 200 Ventilators still have toxic sound abatement foam residue, and the adhesive on the replacement foam may fail, blocking the ventilator.
It is the latest stumble in the company's efforts to remediate and replace recalled Philips CPAP devices and ventilators
Nearly 60,000 additional Philips Respironics ventilators are being recalled due to power failures which have already led to at least one patient death.
Several injuries and at least one death have been linked to problems with Philips ventilators that are now part of a new recall
An expired adhesive could lead to the ventilator failing during use, at which point it may or may not activate an alarm.